Goserelin

Goserelin

SCHEMBL4080889

CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O.Cl

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GNRHR

The experimentally established mechanism targets of Goserelin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GNRHR known ✓ P30968 2/20 0.62
ABCC2 Q92887 1/20 0.62
PTGS1 P23219 1/20 0.62
C5AR1 P21730 2/20 0.54
APLNR P35414 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Goserelin SCHEMBL14193129 1.00 GNRHR (0.63) GNRHRABCC2PTGS1C5AR1APLNR
Goserelin SCHEMBL7544569 1.00 GNRHR (0.63) GNRHRABCC2PTGS1C5AR1APLNR
Goserelin SCHEMBL29833872 1.00 GNRHR (0.63) GNRHRABCC2PTGS1C5AR1APLNR
Goserelin SCHEMBL8643 1.00 GNRHR (0.63) GNRHRABCC2PTGS1C5AR1APLNR
Goserelin SCHEMBL13660188 1.00 GNRHR (0.63) GNRHRABCC2PTGS1C5AR1APLNR
Goserelin SCHEMBL25243029 1.00 GNRHR (0.63) GNRHRABCC2PTGS1C5AR1APLNR
Goserelin SCHEMBL6094 0.99 ABCC2 (0.64) GNRHRABCC2PTGS1C5AR1APLNR
Goserelin SCHEMBL14485644 0.99 ABCC2 (0.64) GNRHRABCC2PTGS1C5AR1APLNR
Goserelin SCHEMBL22367929 0.99 ABCC2 (0.64) GNRHRABCC2PTGS1C5AR1APLNR
Goserelin SCHEMBL6866961 0.99 GNRHR (0.63) GNRHRABCC2PTGS1C5AR1APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109394705-B Goserelin sustained-release microsphere freeze-dried powder and preparation method thereof 沈阳药科大学 2021-11-19 CN disclosed
CN-108434149-B HSPC-sparing therapy for Rb-positive abnormal cell proliferation G1治疗公司 2021-05-28 CN disclosed
US-10646572-B2 Pharmaceutical compositions with enhanced stability FORESEE PHARMACEUTICALS CO., LTD. (TW) 2020-05-12 US disclosed
US-20190231881-A1 PHARMACEUTICAL COMPOSITIONS WITH ENHANCED STABILITY FORESEE PHARMACEUTICALS CO., LTD. (TW) 2019-08-01 US disclosed
US-10251956-B2 Methods of making pharmaceutical compositions with enhanced stability FORESEE PHARMACEUTICALS CO., LTD. (TW) 2019-04-09 US disclosed
US-20180050108-A1 Methods of Making Pharmaceutical Compositions with Enhanced Stability QUEST PHARMACEUTICAL SERVICES, LLC 2018-02-22 US disclosed
US-9744207-B2 Pharmaceutical compositions with enhanced stability FORESEE PHARMACEUTICALS CO., LTD. (TW) 2017-08-29 US disclosed
US-20170119842-A1 Pharmaceutical Compositions with Enhanced Stability LI YUHUA (US) 2017-05-04 US disclosed
US-9572857-B2 Pharmaceutical compositions with enhanced stability FORESEE PHARMACEUTICALS CO., LTD. (TW) 2017-02-21 US disclosed
US-20160331802-A1 Pharmaceutical Compositions with Enhanced Stability LI YUHUA (US) 2016-11-17 US disclosed
EP-1984009-B1 PHARMACEUTICAL COMPOSITIONS WITH ENHANCED STABILITY QPS LLC (US) 2012-10-24 EP disclosed
EP-1984009-A4 PHARMACEUTICAL COMPOSITIONS WITH ENHANCED STABILITY QPS LLC (US) 2009-08-05 EP disclosed
EP-1984009-A2 PHARMACEUTICAL COMPOSITIONS WITH ENHANCED STABILITY QPS, LLC (US) 2008-10-29 EP disclosed
US-20070196416-A1 Pharmaceutical compositions with enhanced stability QUEST PHARMACEUTICAL SERVICES (US) 2007-08-23 US disclosed
WO-2007084460-A2 PHARMACEUTICAL COMPOSITIONS WITH ENHANCED STABILITY QPS, LLC (US) 2007-07-26 WO disclosed